Everything you should know about the Autologous Stem Cell and Non-Stem Cell Based Therapies
Autologous
Stem Cell and Non-Stem Cell Based Therapies
Stem cells are a unique type of cell that can differentiate
into different types of cells in the body. They are important in the
development and repair of tissues and organs. Stem cells can be categorized
into two main types: embryonic stem cells and adult stem cells. Embryonic stem
cells are derived from embryos, while adult stem cells are found in various
tissues throughout the body, such as bone marrow, adipose tissue, and blood.
Autologous stem cell therapy is a type of stem cell therapy that involves using
the patient’s own stem cells for treatment. Non-stem cell-based therapies, on
the other hand, do not involve the use of stem cells.
According to Coherent
Market Insights the Autologous
Stem Cell and Non-Stem Cell Based Therapies Market Global Industry
Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028
Autologous stem cell therapy involves harvesting stem cells
from the patient’s own body, usually from bone marrow, adipose tissue, or
blood, and then using them to treat a medical condition. This approach has
several advantages over other types of stem cell therapy. Firstly, there is no
risk of rejection, as the stem cells are derived from the patient’s own body.
This means that the patient does not need to take immunosuppressive drugs,
which can have serious side effects. Secondly, autologous stem cell therapy is
more ethical than other types of stem cell therapy, as it does not involve the
use of embryos or other sources of stem cells.
One of the most common types of autologous stem cell therapy
is hematopoietic stem cell transplantation (HSCT). HSCT is used to treat
certain types of cancer, such as leukemia, lymphoma, and multiple myeloma, as
well as some non-cancerous conditions, such as sickle cell disease and thalassemia.
In HSCT, the patient’s bone marrow is first destroyed using chemotherapy or
radiation therapy. This destroys the cancer cells, but it also destroys the
patient’s healthy blood cells. The patient is then given an infusion of
hematopoietic stem cells, which migrate to the bone marrow and start producing
new blood cells.
Comments
Post a Comment